# CoolSculpting® Elite for Non-Invasive Fat Reduction

> **NCT04897867** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 110 (actual)

## Conditions studied

- Non-invasive Fat Reduction

## Interventions

- **DEVICE:** CoolSculpting® Elite System with CoolSculpting® Elite applicators

## Key facts

- **NCT ID:** NCT04897867
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-18
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897867, "CoolSculpting® Elite for Non-Invasive Fat Reduction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04897867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*